{"id":548999,"date":"2021-06-22T21:12:01","date_gmt":"2021-06-22T21:12:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=548999"},"modified":"2021-06-22T21:12:01","modified_gmt":"2021-06-22T21:12:01","slug":"postoperative-pain-market-will-grow-at-a-cagr-of-793-during-the-study-period-201830-according-to-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/postoperative-pain-market-will-grow-at-a-cagr-of-793-during-the-study-period-201830-according-to-delveinsight_548999.html","title":{"rendered":"Postoperative Pain Market will Grow at a CAGR of 7.93% During the Study Period (2018-30), According to DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1624357517.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Postoperative Pain Market will Grow at a CAGR of 7.93% During the Study Period (2018-30), According to DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1624357517.png\" alt=\"Postoperative Pain Market will Grow at a CAGR of 7.93% During the Study Period (2018-30), According to DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Postoperative Pain Market <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s Postoperative Pain market report provides an in-depth understanding of Postoperative Pain, historical and forecasted epidemiology, and Postoperative Pain market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/b1d00ed8702008ecbae66c03efd9b7d2.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&rsquo;s <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/postoperative-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Postoperative Pain market report<\/a><\/strong> provides an in-depth understanding of Postoperative Pain, historical and forecasted epidemiology, and Postoperative Pain market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some Key Highlights from the Postoperative Pain Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to DelveInsight Postoperative Pain epidemiology insights, the total incident cases was estimated to be more than&nbsp;<strong>60 million<\/strong> in 2020 in 7MM.&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In 2020, Germany had the most cases of Postoperative Pain among the EU5, with over <strong>4 million<\/strong> cases while Spain, on the other hand, had the lowest number of Postoperative Pain cases in 2020.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to DelveInsight, the Postoperative Pain severity-specific incident cases in the US for moderate cases was maximum, followed by mild&nbsp; and severe cases in 2020.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Korsuva<\/strong> (Cara Therapeutics), <strong>VVZ-149<\/strong> (Vivozon Inc.), <strong>Tramadol IV<\/strong> (Avenue Therapeutics, Inc.), <strong>PRF-110<\/strong> (PainReform LTD), <strong>F14\/mdc-CWM (Celecoxib)<\/strong> (Arthritis Innovation Corporation\/MedinCell), <strong>NVK-009<\/strong> (Nevakar, Inc.), <strong>TLC590<\/strong> (Taiwan Liposome Company (TLC)), <strong>MR-107A-01<\/strong> (Viatris Inc.), <strong>TPU-006<\/strong> (Teikoku Pharma USA, Inc.), <strong>SAF312<\/strong> (Novartis Pharmaceuticals), <strong>OCS-01<\/strong> (Oculis) and others are some of the pipeline therapies in the Postoperative Pain market.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Vivozon Inc., Avenue Therapeutics, Inc., PainReform LTD, Arthritis Innovation Corporation\/MedinCell, Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc., Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis&nbsp;<\/strong>are among the notable companies which are proactively working towards the development of novel therapies in the Postoperative Pain market.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">To get more insights, request sample @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/postoperative-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Postoperative Pain Market Report<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The Postoperative Pain market report<\/strong> covers current treatment practises, developing medications, individual therapies&#8217; Postoperative Pain market share, and present and predicted Postoperative Pain market size from 2018 to 2030, segmented into seven major markets. The report also examines current Postoperative Pain treatment practices\/algorithms, market drivers, market constraints, and unmet medical needs in order to identify and evaluate the market&#8217;s underlying potential.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Postoperative Pain is a brief and expected increase in background pain that occurs following surgical treatment. It&#8217;s a sort of pain that lasts anywhere from a few days to months and is caused by soft tissue damage like a sprained ankle or a paper cut. The discomfort lasts only a few minutes, but it fades as the wounded tissues heal.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Epidemiology Segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Postoperative Pain Total Number of Surgical Procedures<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Postoperative Pain Total Incident Cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Postoperative Pain Severity-Specific Incident Cases&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Treatment Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Current major treatment options for Postoperative Pain are:<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">NSAIDs<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Opioids&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Anesthetics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Others (e.g. Corticosteroids)<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Market<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">The Postoperative Pain market size in the 7MM might grow at a CAGR of 7.93%.&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In the United States, the therapeutic market for Postoperative Pain was USD 2,223 million in 2020.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Germany has the largest Postoperative Pain therapeutic market among the EU5 countries while Spain captured the smallest Postoperative Pain therapeutic market in 2020.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get complete information on market @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/postoperative-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Postoperative Pain Market Analysis<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Pipeline Therapies and Key Companies<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Korsuva: Cara Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">VVZ-149: Vivozon Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Tramadol IV: Avenue Therapeutics, Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">PRF-110: PainReform LTD<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">F14\/mdc-CWM (Celecoxib): Arthritis Innovation Corporation\/MedinCell<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">NVK-009: Nevakar, Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">TLC590: Taiwan Liposome Company (TLC)<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">MR-107A-01: Viatris Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">TPU-006: Teikoku Pharma USA, Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;SAF312: Novartis Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">OCS-01: Oculis<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Market Drivers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Increased patient pool<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Multimodal therapeutic strategies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Awareness of the disease<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Research and developmental strategies<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Market Barriers<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Knowledge and approach towards pain management<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Age-specific treatment (lacks for pediatric and children)<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Ignorance of pain<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Scope for the Report<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coverage:<\/strong> 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Study Period:<\/strong> 2018-30<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Key Companies:<\/strong> Vivozon Inc., Avenue Therapeutics, Inc., PainReform LTD, Arthritis Innovation Corporation\/MedinCell, Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc., Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis, among others.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Key Pipeline Therapies:<\/strong> VVZ-149 (Vivozon Inc.), Tramadol IV (Avenue Therapeutics, Inc.), PRF-110 (PainReform LTD), F14\/mdc-CWM (Celecoxib) (Arthritis Innovation Corporation\/MedinCell), NVK-009 (Nevakar, Inc.), TLC590 (Taiwan Liposome Company (TLC)), MR-107A-01 (Viatris Inc.), TPU-006 (Teikoku Pharma USA, Inc.), SAF312 (Novartis Pharmaceuticals), OCS-01 (Oculis), and others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Postoperative Pain Segmentation:<\/strong> By Geography, By Postoperative Pain therapies<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Analysis:<\/strong> Comparative and conjoint analysis of Postoperative Pain emerging therapies<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Tools Used:<\/strong> SWOT Analysis<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Case Studies<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>KOL&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Analyst&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"81\" \/>\n<col width=\"543\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\">1.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Report Introduction<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">2.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Market Overview at a Glance<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">3.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Market: Future Perspective<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">4.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Executive Summary of Postoperative Pain<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">5.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Disease Background and Overview<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">6.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Epidemiology and Patient Population<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">7.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Patient Journey<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">8.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Marketed Drugs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">9.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Emerging Drugs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">10.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain: Seven Major Market Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">11.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">KOL Views<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">12.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Market Drivers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">13.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative Pain Market Barriers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">14.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">SWOT Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">15.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Unmet Needs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">16.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Postoperative PainReimbursement and Market Access<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">17.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Appendix<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">18.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">DelveInsight Capabilities<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">19.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Disclaimer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">20.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">About DelveInsight<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">For rich insights into Healthcare and Pharmaceutical News, visit <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Pharma, Healthcare and Biotech Blog Posts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Chronic Pain Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get comprehensive historical and forecast analysis of Chronic Pain Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <strong>Aptinyx, Samumed, Biogen, Allodynic Therapeutics, Bayer, MiMedx, Semnur Pharmaceuticals, Pfizer, Eli Lilly and Company,<\/strong> among others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=postoperative-pain-market-will-grow-at-a-cagr-of-793-during-the-study-period-201830-according-to-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=postoperative-pain-market-will-grow-at-a-cagr-of-793-during-the-study-period-201830-according-to-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Postoperative Pain Market DelveInsight\u2019s Postoperative Pain market report provides an in-depth understanding of Postoperative Pain, historical and forecasted epidemiology, and Postoperative Pain market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. DelveInsight&rsquo;s Postoperative &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/postoperative-pain-market-will-grow-at-a-cagr-of-793-during-the-study-period-201830-according-to-delveinsight_548999.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-548999","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/548999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=548999"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/548999\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=548999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=548999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=548999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}